Keys A, Aravanis C, Blackburn HW et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 1966;460:1–392.
Verschuren WM, Jacobs DR, Bloemberg BP et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995;274:131–6.
Davis C, Bryan J, Hodgson J et al. Definition of the Mediterranean diet; a literature review. Nutrients 2015;7:9139–53.
UNESCO Representative list of the intangible cultural heritage of humanity. In: UNESCO (ed) 2010.
Trichopoulou A, Costacou T, Bamia C et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599–608.
Donini LM, Serra-Majem L, Bullo M et al. The Mediterranean diet: culture, health and science. Br J Nutr 2015;113 (Suppl 2): S1–3.
Papamiltiadous ES, Roberts SK, Nicoll AJ et al. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. BMC Gastroenterol 2016;16:14.
Salas-Salvado J, Guasch-Ferre M, Lee CH et al. Protective effects of the Mediterranean diet on type 2 diabetes and metabolic syndrome. J Nutr 2016 doi: 10.3945/jn.115.218487.
Abenavoli L, Milic N, Peta V et al. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J Gastroenterol 2014;20:16831–40.
Sofi F, Cesari F, Abbate R et al. Adherence to Mediterranean diet and health status: meta-analysis. Br Med J 2008;337:a1344.
Karamanos B, Thanopoulou A, Angelico F et al. Nutritional habits in the Mediterranean Basin. The macronutrient composition of diet and its relation with the traditional Mediterranean diet. Multi-centre study of the Mediterranean Group for the Study of Diabetes (MGSD). Eur J Clin Nutr 2002;56:983–91.
Pais R, Barritt AST, Calmus Y et al. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol 2016;65:1245–57.
Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511–31.
European Association for the Study of the Liver. Electronic address eee, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388–402.
Marchesini G, Petta S, Dalle Grave R. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016;63:2032–43.
Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012;56:255–66.
Authors/Task Force M, Ryden L, Grant PJ et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34:3035–87.
Mancia G, Fagard R, Narkiewicz K et al. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013;31:1925–38.
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1–452.
the European Atherosclerosis STask Force for the management of dyslipidaemias of the European Society of CCatapano AL et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217 (Suppl 1): S1–44.
Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52.
Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013;13:47.
Marques-Vidal P, Mazoyer E, Bongard V et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002;25:1371–7.
Hamaguchi M, Kojima T, Itoh Y et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102:2708–15.
Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M et al. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr 2004;58:1550–2.
Martin-Moreno JM, Boyle P, Gorgojo L et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993;22:512–9.
Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M et al. Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur J Nutr 2002;41:153–60.
Pastori D, Carnevale R, Bartimoccia S et al. Does Mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation? Antioxid Redox Signal 2015;23:682–7.
Ratziu V, Bellentani S, Cortez-Pinto H et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372–84.
Ryan MC, Itsiopoulos C, Thodis T et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013;59:138–43.
Trovato FM, Catalano D, Martines GF et al. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 2015;34:86–8.
Fraser A, Abel R, Lawlor DA et al. A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial. Diabetologia 2008;51:1616–22.
Della Corte C, Mosca A, Vania A et al. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: the results of an Italian Study. Nutrition 2017;39-40:8–14.
Babio N, Bullo M, Basora J et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis 2009;19:563–70.
Kani AH, Alavian SM, Esmaillzadeh A et al. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial. Nutrition 2014;30:814–21.
Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007;47:711–7.
Pelucchi C, Galeone C, Negri E et al. Trends in adherence to the Mediterranean diet in an Italian population between 1991 and 2006. Eur J Clin Nutr 2010;64:1052–6.
Allman-Farinelli M, Partridge SR, Roy R. Weight-related dietary behaviors in young adults. Curr Obes Rep 2016;5:23–9.
Garcia Cabrera S, Herrera Fernandez N, Rodriguez Hernandez C et al. Kidmed test; prevalence of low adherence to the Mediterranean diet in children and young; a systematic review. Nutr Hosp 2015;32:2390–9.
Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292:1440–6.
Park YM, Zhang J, Steck SE et al. Obesity mediates the association between mediterranean diet consumption and insulin resistance and inflammation in US adults. J Nutr 2017;147:563–71.
Keita H, Ramirez-San Juan E, Paniagua-Castro N et al. The long-term ingestion of a diet high in extra virgin olive oil produces obesity and insulin resistance but protects endothelial function in rats: a preliminary study. Diabetol Metab Syndr 2013;5:53.
Chen JH, Song J, Chen Y et al. The effect of vegan protein-based diets on metabolic parameters, expressions of adiponectin and its receptors in wistar rats. Nutrients 2016;8:643 doi:10.3390/nu8100643.
Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008;47:1947–54.
Garcia M, Bihuniak JD, Shook J et al. The effect of the traditional Mediterranean-style diet on metabolic risk factors: a meta-analysis. Nutrients 2016;8:168.
Zamora-Ros R, Serafini M, Estruch R et al. Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: evidence for a mechanism of antioxidant tuning. Nutr Metab Cardiovasc Dis 2013;23:1167–74.
Spahis S, Delvin E, Borys JM et al. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal 2017;26:519–41.
Polimeni L, Del Ben M, Baratta F et al. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol 2015;7:1325–36.
Evans JL, Goldfine ID, Maddux BA et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1–8.
Del Ben M, Polimeni L, Carnevale R et al. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2014;14:81.
Eckel RH, Jakicic JM, Ard JD et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S76–99.